Worcester HIV Vaccine

Worcester HIV Vaccine (WHV) is a biotechnology company dedicated to developing an effective vaccine to prevent HIV infections worldwide. Through global partnerships, WHV is developing the most advanced multivalent DNA-prime/protein-boost vaccine, which will provide broad immune protection against globally prevalent HIV strains. WHV collaborates with research institutions, government agencies, biotech companies, and other organizations to test the safety and efficacy of its candidate vaccine. It is also developing and optimizing biomanufacturing processes to accelerate and enhance the large-scale clinical trials and market rollout of the multivalent candidate vaccine.